Drug Profile
Research programme: stroke and acute vascular events therapeutics - InVasc Therapeutics
Alternative Names: INV-155; INV-311Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator InVasc Therapeutics
- Class
- Mechanism of Action Peroxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Stroke; Vascular disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Stroke in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Vascular-disorders in USA
- 27 Jun 2011 Preclinical trials in Stroke in USA (unspecified route)